- Release Date: 27/05/21 08:47
- Summary: NEXTSTELLIS FDA exclusivity & phase III data published
- Price Sensitive: No
- Download Document 223.51KB
- Forums
- ASX - By Stock
- MYX
- Ann: NEXTSTELLIS FDA exclusivity & phase III data published
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.03

Ann: NEXTSTELLIS FDA exclusivity & phase III data published
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.03 |
Change
0.010(0.20%) |
Mkt cap ! $405.4M |
Open | High | Low | Value | Volume |
$5.00 | $5.03 | $4.94 | $246.2K | 49.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 407 | $5.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.04 | 448 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 43 | 4.980 |
14 | 727 | 4.970 |
4 | 4718 | 4.960 |
3 | 7996 | 4.950 |
5 | 12477 | 4.940 |
Price($) | Vol. | No. |
---|---|---|
4.990 | 2729 | 7 |
5.000 | 25970 | 3 |
5.010 | 596 | 2 |
5.020 | 125 | 1 |
5.030 | 571 | 2 |
Last trade - 11.54am 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online